RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.926
EU - Europa 17.023
AS - Asia 14.446
SA - Sud America 2.016
AF - Africa 357
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 24
Totale 65.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.471
GB - Regno Unito 4.993
IT - Italia 4.249
SG - Singapore 4.081
CN - Cina 4.061
SE - Svezia 3.137
HK - Hong Kong 1.848
BR - Brasile 1.544
VN - Vietnam 1.526
DE - Germania 949
UA - Ucraina 653
TR - Turchia 650
RU - Federazione Russa 639
FI - Finlandia 606
FR - Francia 552
KR - Corea 490
IN - India 365
BD - Bangladesh 347
BG - Bulgaria 245
CA - Canada 205
NL - Olanda 186
ID - Indonesia 173
AR - Argentina 153
IQ - Iraq 136
MX - Messico 130
JP - Giappone 124
IE - Irlanda 118
ZA - Sudafrica 112
ES - Italia 105
RO - Romania 91
PK - Pakistan 89
BE - Belgio 85
PL - Polonia 83
AE - Emirati Arabi Uniti 74
CO - Colombia 72
EC - Ecuador 72
LT - Lituania 62
CH - Svizzera 49
VE - Venezuela 48
EG - Egitto 47
IR - Iran 45
MY - Malesia 44
AU - Australia 41
MA - Marocco 41
CL - Cile 38
PH - Filippine 38
UZ - Uzbekistan 37
PY - Paraguay 36
CZ - Repubblica Ceca 32
JO - Giordania 31
AT - Austria 30
IL - Israele 30
TN - Tunisia 30
SA - Arabia Saudita 29
DZ - Algeria 28
TH - Thailandia 28
JM - Giamaica 27
NP - Nepal 24
PT - Portogallo 24
GR - Grecia 23
KE - Kenya 22
TW - Taiwan 22
UY - Uruguay 19
AZ - Azerbaigian 17
ET - Etiopia 17
KZ - Kazakistan 17
CR - Costa Rica 16
EU - Europa 16
PE - Perù 16
BO - Bolivia 15
SN - Senegal 15
DK - Danimarca 14
KG - Kirghizistan 14
DO - Repubblica Dominicana 13
LB - Libano 13
RS - Serbia 13
AL - Albania 12
BY - Bielorussia 12
HU - Ungheria 12
TT - Trinidad e Tobago 12
PR - Porto Rico 10
NZ - Nuova Zelanda 9
OM - Oman 9
PA - Panama 9
HN - Honduras 8
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
QA - Qatar 8
CY - Cipro 7
HR - Croazia 7
LK - Sri Lanka 7
NO - Norvegia 7
AM - Armenia 6
EE - Estonia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
MN - Mongolia 6
NG - Nigeria 6
NI - Nicaragua 6
Totale 65.730
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Ashburn 2.886
Santa Clara 2.816
Singapore 2.501
Fairfield 2.350
Stockholm 1.818
Hong Kong 1.817
Chandler 1.757
Woodbridge 1.635
Hefei 1.335
Chicago 1.295
Jacksonville 1.265
Houston 1.093
San Jose 1.064
Seattle 997
Wilmington 992
Dearborn 954
Ann Arbor 918
Beijing 817
Cambridge 798
Nyköping 775
Los Angeles 744
London 632
Modena 538
Council Bluffs 512
Ho Chi Minh City 499
Seoul 431
Salt Lake City 386
The Dalles 380
Izmir 359
Helsinki 355
New York 353
Hanoi 339
Milan 284
Dallas 255
Princeton 249
Sofia 234
Eugene 220
San Diego 213
Lauterbourg 203
Rome 182
Tampa 179
Buffalo 178
Moscow 168
Bologna 163
Elk Grove Village 163
São Paulo 143
Shanghai 142
Munich 126
Des Moines 119
Orem 119
Jakarta 116
Redwood City 112
Frankfurt am Main 107
Lancaster 105
Tokyo 97
Bremen 94
Dublin 94
Fremont 90
Falls Church 88
Phoenix 82
Columbus 76
Miami 74
Brussels 73
Reggio Emilia 73
Chennai 69
Sterling 69
Naples 68
Boardman 62
Da Nang 59
Haiphong 59
Guangzhou 58
Florence 56
Dulles 54
Johannesburg 54
Warsaw 54
Toronto 52
Amsterdam 51
Montreal 50
Baghdad 49
Parma 49
Brooklyn 48
Detroit 46
Turin 46
Atlanta 44
Nanjing 44
Como 42
Catania 41
Bari 40
Denver 39
Mexico City 39
Kent 37
Norwalk 37
Rio de Janeiro 37
Washington 36
Boston 35
Kansas City 35
Miano 35
Tulare 33
Manchester 32
Totale 45.508
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.032
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 583
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 493
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 475
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 459
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 455
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 435
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 431
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 428
Cationic liposomes for gene transfection 420
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 416
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 416
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 405
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 395
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 395
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 394
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 393
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Amphiphilic ion pairs of tobramycin with lipoamino acids 386
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 385
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 375
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 372
Vegetable cells in Papanicolaou-stained cervical smears 367
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 366
Polymeric nanoparticles for the drug delivery to the central nervous system 364
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Nanomedicine: the future for advancing medicine and neuroscience 358
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 357
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 357
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 355
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 352
Protein corona and nanoparticles: How can we investigate on? 351
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
Brain targeting with polymeric nanoparticles: which administration route should we take? 347
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 347
Nanoparticle transport across the blood brain barrier 343
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 338
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 336
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 336
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 332
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 332
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 330
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 330
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 329
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 326
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 322
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 320
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 319
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 318
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 316
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 315
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 313
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 312
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 312
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 311
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 310
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 309
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 308
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 306
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 305
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 304
Functionalization of liposomes: microscopical methods for preformulative screening 304
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 304
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 302
PLA/PLGA nanoparticles for sustained release of docetaxel 301
Colloidal systems for CNS drug delivery 299
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 297
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 296
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 296
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 295
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 293
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 293
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 289
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 283
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 280
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 280
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 275
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 275
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 274
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 272
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 271
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 271
Brain targeting by engineered nanoparticles 271
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 269
Totale 36.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 243.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 243.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 0 0 0 0 0 0 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202622.858 1.329 851 1.566 2.785 4.348 1.379 2.238 1.032 3.875 1.985 1.172 298
Totale 66.253